AR and cancer: KAT2A has also been shown to play a critical role in carcinogenesis and the progression of several cancers [30, 34, 35]; however, there are no reports of the impact of KAT2A on the non-histone acetylation of AR, and its potential role in primary or secondary resistance to abiraterone.